| Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching … A Alamer, AA Alrashed, M Alfaifi, B Alosaimi, F AlHassar, M Almutairi, ... Current medical research and opinion 37 (7), 1085-1097, 2021 | 34 | 2021 |
| Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies OS Alkhezi, HA Alsuhaibani, AA Alhadyab, ME Alfaifi, B Alomrani, ... Primary Care Diabetes 15 (5), 761-771, 2021 | 7 | 2021 |
| Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study K Al Sulaiman, O Aljuhani, GB Korayem, A Hafiz, M Alalawi, HA Badreldin, ... Thrombosis Journal 20 (1), 74, 2022 | 6 | 2022 |
| Prevalence of contraceptive use and its association with depression among women in the Jazan province of Saudi Arabia M Alfaifi, AH Najmi, KH Swadi, AA Almushtawi, SA Jaddoh Journal of Family Medicine and Primary Care 10 (7), 2503-2511, 2021 | 6 | 2021 |
| A national survey of self-prescription of beta-blockers and their relation to undiscovered anxiety among medical and pharmacological students in Saudi Arabia A Alsini, I Alkhodaidi, Y Alsini, S Alsseeni, S Alkhodaidi, E Alsini, A Alsini, ... Neuropsychiatric Disease and Treatment, 797-807, 2021 | 6 | 2021 |
| Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals A Alamer, AR Almutairi, S Halloush, A Al-Jedai, A Alrashed, M AlFaifi, ... Saudi Pharmaceutical Journal 31 (4), 510-516, 2023 | 5 | 2023 |
| Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with COVID-19: A Multicenter Cohort Study R Kensara, O Aljuhani, GB Korayem, H Alkofide, SN Almohareb, ... Clinical and Applied Thrombosis/Hemostasis 29, 10760296231156178, 2023 | 3 | 2023 |
| The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study O Aljuhani, GB Korayem, AF Altebainawi, MS Alotaibi, NA Alrakban, ... Saudi Pharmaceutical Journal 31 (7), 1210-1218, 2023 | 2 | 2023 |
| A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient S Al Harbi, M AlFaifi, HM Al-Dorzi, O Aljuhani, AA Alenazi, M Alalawi, ... IDCases 29, e01572, 2022 | 2 | 2022 |
| A community-based survey of malaria and its prevention in Jazan, Saudi Arabia R Tripathi, HA Makeen, AA Albarraq, P Tripathi, AM Meraya, AA Mubaraki, ... International Journal of Health Promotion and Education 58 (1), 28-41, 2020 | 2 | 2020 |
| The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: A multicenter, cohort study O Aljuhani, K Al Sulaiman, G B Korayem, A Alharbi, AF Altebainawi, ... Renal Failure 45 (2), 2268213, 2023 | 1 | 2023 |
| Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study K Al Sulaiman, O Aljuhani, GB Korayem, A Altebainawi, R Alharbi, ... BMC Pulmonary Medicine 23 (1), 315, 2023 | 1 | 2023 |
| Thromboprophylaxis in hospitalized Non-Critically ill patients with mild-to-Moderate COVID-19 infection: a systematic review and Meta-Analysis A Hafiz, H Alkofide, K Al Sulaiman, H Joharji, S Aljohani, KA Sarkhi, ... Clinical and Applied Thrombosis/Hemostasis 29, 10760296231191123, 2023 | 1 | 2023 |
| A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data A Alrashed, P Cahusac, YA Mohzari, RF Bamogaddam, M Alfaifi, ... Frontiers in Cardiovascular Medicine 9, 978420, 2022 | 1 | 2022 |
| The concomitant use of Beta Blockers with vasopressors/inotropes in critically ill patients with septic shock: A systematic review and meta-analysis KA Al Sulaiman, HA Alkofide, ME AlFaifi, SS Aljohani, AF Al Harthi, ... Saudi Pharmaceutical Journal, 102094, 2024 | | 2024 |
| Ketamine-based sedation use in mechanically ventilated critically ill patients with COVID-19: A multicenter cohort study O Aljuhani, K Al Sulaiman, GB Korayem, AF Altebainawi, A Alshaya, ... Saudi Pharmaceutical Journal 32 (5), 102061, 2024 | | 2024 |
| Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study K Al Sulaiman, O Aljuhani, H Alkofide, MA Aljohani, HA Badreldin, ... Thrombosis Journal 22, 2024 | | 2024 |
| Evaluation of the Safety and Effectiveness of Topical Intrapleural Application of Tranexamic Acid in Thoracic Surgery: A Systematic Review and Meta-Analysis of Randomized … A Alzahrani, H Alkofide, H Joharji, GB Korayem, S Aljohani, H Alshareef, ... Clinical and Applied Thrombosis/Hemostasis 29, 10760296231218215, 2023 | | 2023 |
| The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study K Al Sulaiman, O Aljuhani, GB Korayem, AF Altebainawi, R Vishwakarma, ... Clinical and Applied Thrombosis/Hemostasis 29, 10760296231218216, 2023 | | 2023 |
| Research barriers in Saudi pharmacy residency training programs OM Alfayez, M AlFaifi, OS Alkhezi, AA Alahmed, AA Alalwan Saudi Pharmaceutical Journal 31 (12), 101842, 2023 | | 2023 |
Dr. Khalid Al SulaimanKing Abdulaziz Medical CityVerified email at ngha.med.sa
